View: 2

One Vial, Two Researchers: What an HPLC Purity Figure Can and Cannot Prove

When two colleagues draw from the same stock vial, an HPLC purity figure can feel like a shared guarantee. It…
Science

When two colleagues draw from the same stock vial, an HPLC purity figure can feel like a shared guarantee. It is not. It is a batch-level observation for a submitted sample, produced under a particular method and reported as a relative percentage. It can support a decision to proceed with an in-vitro study, but it cannot replace batch reconciliation, identity checks, handling records or risk assessment. The practical question is not only “what is the purity?” but “which sample does the figure describe, and what has happened to the stock since testing?”

What an HPLC Purity Percentage Represents

In reversed-phase HPLC, purity is often based on the proportion of total peak area accounted for by the main peak at a chosen wavelength. A figure such as ≥99% means that, within that method, the main peak dominates the detected signal. It can indicate that major UV-active impurities are low or below the reporting threshold. It does not establish chemical identity, counter-ion form, water content, residual solvents, heavy metals, endotoxin burden, sterility or biological activity. Method, column, gradient, wavelength and integration rules all shape the result, so the number should be read with the CoA, not in isolation.

Research Sciences currently publishes “≥99% Verified Purity” and “UK Research Materials Over 99.1% Purity” on its homepage, and its FAQs state that peptides are typically supplied at ≥99% purity (HPLC tested), with exact purity stated on the CoA. Those are the shop’s published figures and should be reconfirmed on the live site and against the CoA for the specific batch. The homepage also lists “CoAs Janoshik Analytical Reports”; researchers should open the CoA accompanying the vial rather than treating a headline claim as a batch-specific finding. A published range does not reconcile two deliveries, two vials or two colleagues’ records.

Purity is not quantity. A high percentage does not confirm mass, fill accuracy or concentration after reconstitution. If an in-vitro assay depends on a nominal concentration, the group still needs a documented weighing, dilution and aliquoting workflow. Purity is also not stability. A sample that passed at release can change after repeated freeze–thaw cycles, moisture, light or warm conditions. The figure describes the tested sample at testing time; it does not follow the vial through every opening and transfer.

What the Figure Cannot Tell Two Colleagues Sharing Stock

Shared stock creates a documentation problem before it creates a scientific one. Two colleagues may hold vials that look identical, yet they may have arrived in different deliveries, been stored differently or been opened under different conditions. The CoA is batch-linked, so it should be filed with the label reference and internal stock record. Research Sciences uses vial labels that combine SKU code and expiry date, for example a reference in the style BPC10-03/27; the shop asks researchers to quote that reference when contacting it about documentation. That reference is more useful than cap colour, because the FAQs state that cap colours and other packaging may vary and are not indicators of identity, analytical quality or manufacturing origin.

The FAQs also note that restocked products may carry the same Internal Test Reference (ITR) as earlier stock. An ITR links to associated sample testing reports, but it does not confirm that separate deliveries come from the same production lot or have had separate independent testing. For a shared stock, this distinction matters. Same ITR is not the same as same lot. A purity figure attached to one report cannot be assumed to apply to a later delivery unless the batch documentation and label reference support that conclusion. When a second colleague is sourcing replacement research materials through Uk peptides or another catalogue route, the new batch CoA should still be compared with the retained record rather than assumed equivalent.

HPLC purity also cannot tell either colleague whether stock has followed the same in-vitro workflow. Lyophilised material should reach room temperature before opening, be handled in a clean environment and be kept sealed with desiccant at −20°C or below, protected from moisture, heat and light. Remove only the amount required for the experiment and avoid repeated freeze–thaw cycles. Reconstituted material is less stable and should be stored at 2–8°C for short-term laboratory use. These are handling controls, not purity claims, and they belong in the shared record. All such materials are research-use-only and not for human or veterinary use, consumption, administration or clinical application.

Practical Reconciliation Before the First Shared Aliquot

A materials manager can reduce ambiguity by requiring a shared-stock entry before the vial is opened. Record the product name, SKU, label reference, expiry date, ITR or batch identifier, CoA file location, date received, storage location, opening date and first handler. If the group aliquots stock, each sub-vial should carry an internal code tied back to that entry, plus any reconstitution or dilution details relevant to the in-vitro assay. A purity percentage should never be the primary identifier. The CoA and label reference are the audit trail; the percentage is one line within it.

Where reconstitution is needed for an in-vitro workflow, record the diluent volume, target laboratory concentration, container, date and storage condition, and keep the calculation with the assay record. The free peptide reconstitution calculator described by Research Sciences is for laboratory research use only and must not be used for human or veterinary dosing. The FAQs state that all peptides contain trace amounts of mannitol as an excipient; this can affect weighing, dissolution and vial appearance, so note it in the shared record rather than treating it as an impurity or identity marker. The shop also states that it does not supply blended peptides and recommends buying peptides individually and combining only within a controlled experimental design.

If documentation appears inconsistent, pause shared use and compare the vial label with the CoA, ITR and delivery record. Quote the label reference when contacting the supplier. Research Sciences publishes CoAs for every product and describes batch-level analytical verification, but those are the shop’s stated arrangements; verify the actual batch document and reconfirm current wording on the live site. Any material that cannot be reconciled should be quarantined under the laboratory’s own procedures, and all products remain strictly research-use-only and not for human or veterinary use.

Zoila Márquez

From Oaxaca’s mezcal hills to Copenhagen’s bike lanes, Zoila swapped civil-engineering plans for storytelling. She explains sustainable architecture, Nordic pastry chemistry, and Zapotec weaving symbolism with the same vibrant flair. Spare moments find her spinning wool or perfecting Danish tongue-twisters.